Fifth Third Bancorp
DFTX

Fifth Third Bancorp’s Definium Therapeutics DFTX Stock Holding History

Fifth Third Bancorp’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Hold
3,300
– – ﹤0.01% 2738
2026
Q1 		$62.4K Hold
3,300
– – ﹤0.01% 3114
2025
Q4 		$44.2K Sell
3,300
-59
-2% -$730 ﹤0.01% 1522
2025
Q3 		$39.6K Buy
3,359
+3,300
+5,593% +$30.8K ﹤0.01% 1598
2025
Q2 		$383 Hold
59
– – ﹤0.01% 2508
2025
Q1 		$345 Hold
59
– – ﹤0.01% 2466
2024
Q4 		$411 Hold
59
– – ﹤0.01% 2475
2024
Q3 		$336 Buy
+59
New +$410 ﹤0.01% 2514

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fifth Third Bancorp's DFTX Position: Q2 2026 in Review

Fifth Third Bancorp held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 3,300 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

Fifth Third Bancorp first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Fifth Third Bancorp held 3,300 shares of Definium Therapeutics worth $155K as of Q2 2026.
  • Fifth Third Bancorp left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2738 holding.
  • Fifth Third Bancorp first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.